TBX3 activating PVT1 accelerates proliferation, migration, and invasion by modulating the miR-30a/LOX axis in

Jing Wen1,2, Wei Zhang3, Yan Zhou2

  • 1Department of Ultrasound Centre, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Endokrynologia Polska
|August 16, 2022
PubMed
Abstract

Insights

The transcription factor TBX3 promotes anaplastic thyroid carcinoma (ATC) progression by upregulating the long non-coding RNA PVT1. This pathway involves the miR-30a/LOX signaling axis, impacting cell proliferation, migration, and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Anaplastic thyroid carcinoma (ATC) is an aggressive cancer with poor prognosis.
  • Long non-coding RNAs (lncRNAs) are implicated in ATC development and progression.
  • Understanding the regulatory mechanisms of lncRNAs in ATC is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the role and mechanism of PVT1 dysregulation in anaplastic thyroid carcinoma.
  • To elucidate the relationship between transcription factor TBX3 and PVT1 expression in ATC.
  • To explore the downstream signaling pathway regulated by TBX3 and PVT1.

Main Methods:

  • Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and western blot were used to measure PVT1 and TBX3 levels.
  • Bioinformatic tools (JASPAR) and experimental assays (ChIP, luciferase) validated TBX3 binding to the PVT1 promoter.
  • Cellular assays (MTT, colony formation, transwell) assessed the impact of PVT1 on cell proliferation, migration, and invasion.

Main Results:

  • PVT1 expression was significantly upregulated in ATC tissues and correlated with TBX3 levels.
  • Downregulation of PVT1 suppressed proliferation, migration, and invasion of ATC cells.
  • TBX3 directly targeted the PVT1 promoter, enhancing PVT1 expression and modulating the PVT1/miR-30a/LOX axis.

Conclusions:

  • TBX3 acts as a positive regulator of ATC cell proliferation, migration, and invasion.
  • The TBX3-PVT1 axis plays a critical role in ATC pathogenesis.
  • Targeting the TBX3-PVT1-miR-30a/LOX pathway may offer a therapeutic strategy for ATC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.0K